TKG휴켐스

069260KOSPI기타 화학제품 제조업

59.5 / 100

Reference Date: 2026-07-24

Financial Score26.0 / 40

News Sentiment17.5 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

TKG Hukemsys operates as a precision chemical manufacturer, specializing in producing intermediate materials for polyurethane, including the NT series (DNT, MNB) and the NA series (稀硫酸, 农硫酸, 超酸). In 2024, the NT series accounted for 66% of total sales, while the NA series contributed 31%. Additionally, the company generates 3% of its revenue from ammonia-based products and carbon credit sales.

Number of Employees

298people

Average Salary

107.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.84Industry Average 16.676.5Point

Lower than industry avg (good)

PBR

0.69Industry Average 1.065.5Point

Lower than industry avg (good)

ROE

6.64Industry Average 4.554.0Point

In line with industry avg

Debt Ratio

3.85Industry Average 8.136.5Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲3.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼26.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 10.9% (declining, 3yr)

Detailed News Sentiment

15 totalPositive 9Neutral 5Negative 1Average Sentiment Score 70

Positive
에이프릴바이오, 3468억원 납입 완료…TKG휴켐스로 경영권 이전
에이프릴바이오의 경영권 이전으로 TKG휴켐스는 추가 자금 확보를 통해 임상 및 신규 파이프라인 투자에 유리한 위치에 놓였다.
Positive
에이프릴바이오, TKG태광·IMM인베스트먼트서 투자 유치 완료
에이프릴바이오의 대규모 투자 유치로 TKG휴켐스 관련 기업의 성장 기대감 증가.
Positive
에이프릴바이오, RNA 신약 개발 나선다
에이프릴바이오의 큐리진 인수로 TKG휴켐스 관련 RNA 치료제 개발 분야에서의 협력 강화로 긍정적 영향 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 15,360Won52-week high 21,20052-week low 14,950

1-month return3.0Point

1m -0.78% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral[기재정정]타법인주식및출자증권취득결정2026-07-23
Neutral타법인주식및출자증권취득결정2026-06-25